PrimeGen Energy Corp. (PGNE)

[alien42]

"As of September 30, 2009. The Company had 233,090,000 shares of its Common Stock outstanding with 7 stockholders of record. Of this amount 35,590,000 shares were freely tradable and 197,500,000 shares are “restricted securities” as that term is used under the Securities Act of 1933. PrimeGen is currently authorized by the Articles of Incorporation of the Company to issue 1,500,000,000 number of common stock with .001 par value. The Company has 2,478 beneficial stockholders."

The party acting as the transfer agent for PGNE is:
Pacific Stock Transfer Co.
500 E. Warm Springs Road, Suite 240
Las Vegas, NV 89119
Tel: [phone]
Fax: [phone]



"The Debenture holders shall be issued three (3) separate warrants. The Series A Warrant gives the holder the right to purchase, for two years, 100% of PrimeGen common shares underlying the Debenture at $.50 per share. The Series B Warrant gives the holder the right to purchase, for two years from the effective date of a registration statement, a number of PrimeGen common shares equal to 50% of the number of common shares underlying the debenture, at $.35 per share. The Series C Warrant has a 7-year term and has an exercise price of $.45 per share, but may only be exercised by a Debenture holder who has exercised an equal number of Series B Warrants.
The Company has the right to force the Series A warrant holders to exercise their warrants if PrimeGen's stock price exceeds $.80 per share. PrimeGen has the right to force the Series B warrant holders to exercise their warrants if PrimeGen's stock price exceeds $.50 per share. The Debenture holders also are restricted or gated in terms of the number of shares underlying the Debenture that they may convert."





*18 boardmarks